Haiming Jiang

2.1k total citations · 1 hit paper
50 papers, 1.5k citations indexed

About

Haiming Jiang is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Haiming Jiang has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Haiming Jiang's work include Influenza Virus Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and COVID-19 Clinical Research Studies (6 papers). Haiming Jiang is often cited by papers focused on Influenza Virus Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and COVID-19 Clinical Research Studies (6 papers). Haiming Jiang collaborates with scholars based in China, Macao and United States. Haiming Jiang's co-authors include Zifeng Yang, Runfeng Li, Qinhai Ma, Jun Dai, Jicheng Huang, Jin Zhao, Kui Zheng, Chufang Li, Weiqi Pan and Yongxia Shi and has published in prestigious journals such as Cancer Research, Food Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Haiming Jiang

47 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

2020 495 citations Runfeng Li, Qinhai Ma et al. Pharmacological Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haiming Jiang China	19	510	413	299	274	260	50	1.5k
Runfeng Li China	16	392 0.8×	509 1.2×	326 1.1×	215 0.8×	303 1.2×	47	1.4k
Young-Hee Jin South Korea	22	405 0.8×	373 0.9×	169 0.6×	440 1.6×	114 0.4×	82	1.5k
Su‐Hua Huang Taiwan	20	547 1.1×	330 0.8×	168 0.6×	235 0.9×	151 0.6×	29	1.6k
Chufang Li China	21	557 1.1×	567 1.4×	225 0.8×	275 1.0×	212 0.8×	45	1.7k
Gabriele Bauer Germany	8	337 0.7×	891 2.2×	523 1.7×	267 1.0×	238 0.9×	9	1.9k
J Cinátl Germany	9	301 0.6×	567 1.4×	516 1.7×	273 1.0×	229 0.9×	15	1.4k
Shih‐Chao Lin United States	21	425 0.8×	362 0.9×	122 0.4×	124 0.5×	102 0.4×	53	1.3k
Yin Kwan Wong China	20	676 1.3×	221 0.5×	107 0.4×	117 0.4×	74 0.3×	48	1.5k
Mengzhu Zheng China	18	1.1k 2.2×	1.1k 2.6×	210 0.7×	182 0.7×	207 0.8×	49	2.8k

Countries citing papers authored by Haiming Jiang

Since Specialization

Citations

This map shows the geographic impact of Haiming Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiming Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiming Jiang more than expected).

Fields of papers citing papers by Haiming Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiming Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiming Jiang. The network helps show where Haiming Jiang may publish in the future.

Co-authorship network of co-authors of Haiming Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Haiming Jiang. A scholar is included among the top collaborators of Haiming Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiming Jiang. Haiming Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Duo, Wen‐Fang Tang, Tao Jiang, et al.. (2025). Deciphering genomic evolution of metastatic organotropism with 535 paired primary lung cancers and metastases. Cell Reports. 44(10). 116449–116449.

Wang, Jian & Haiming Jiang. (2024). A novel mitochondrial function-associated programmed cell death-related prognostic signature for predicting the prognosis of early breast cancer. Frontiers in Genetics. 15. 1406426–1406426. 2 indexed citations

Pan, Hudan, Xiaojun Yao, Han Zhang, et al.. (2023). Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice. Phytomedicine. 116. 154858–154858. 23 indexed citations

Wu, Xiao Y., Runfeng Li, Zhengshi Lin, et al.. (2023). Coinfection with influenza virus and non-typeable Haemophilus influenzae aggregates inflammatory lung injury and alters gut microbiota in COPD mice. Frontiers in Microbiology. 14. 1137369–1137369. 11 indexed citations

Ma, Qinhai, Biao Lei, Ruihan Chen, et al.. (2022). Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro. Chinese Medicine. 17(1). 40–40. 9 indexed citations

Li, Runfeng, Xiaobo Zhou, Hongxia Zhou, et al.. (2021). Novel Fatty Acid in Cordyceps Suppresses Influenza A (H1N1) Virus-Induced Proinflammatory Response Through Regulating Innate Signaling Pathways. ACS Omega. 6(2). 1505–1515. 14 indexed citations

Ma, Qinhai, Yuqi Xie, Zhoulang Wang, et al.. (2021). Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2. Journal of Ethnopharmacology. 279. 114367–114367. 26 indexed citations

Jiang, Yanan, et al.. (2021). Hypoxia enhances the production and antitumor effect of exosomes derived from natural killer cells. Annals of Translational Medicine. 9(6). 473–473. 36 indexed citations

Hamdoun, Sami, Ruihong Chen, Yuan Qing Qu, et al.. (2021). Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacological Research. 172. 105820–105820. 69 indexed citations

10.

Wu, Xiao Y., Runfeng Li, Yunceng Weng, et al.. (2021). Correlation of adhesion molecules and non-typeable haemophilus influenzae growth in a mice coinfected model of acute inflammation. Microbes and Infection. 23(8). 104839–104839. 6 indexed citations

11.

Wang, Liqiang, et al.. (2020). Vascular Complications of Lower Limb Ischemia in Patients with Femoral Venoarterial Extracorporeal Membrane Oxygenation. The Heart Surgery Forum. 23(3). E305–E309. 3 indexed citations

12.

Zhou, Hongxia, Runfeng Li, Yifeng Wang, et al.. (2020). Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response. Phytomedicine. 77. 153272–153272. 30 indexed citations

13.

Gu, Zhen, Irina A. Leneva, Haiming Jiang, et al.. (2019). The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis. International Immunopharmacology. 68. 58–67. 20 indexed citations

14.

Zhao, Xin, Runfeng Li, Yang Zhou, et al.. (2018). Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses. Journal of Medicinal Chemistry. 61(12). 5187–5198. 27 indexed citations

15.

Li, Zhengtu, Junling Zhao, Hongxia Zhou, et al.. (2018). Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo. Life Sciences. 200. 115–125. 14 indexed citations

16.

Jiang, Haiming, Rong Deng, Jialin Shang, et al.. (2017). Peptidomimetic inhibitors of APC–Asef interaction block colorectal cancer migration. Nature Chemical Biology. 13(9). 994–1001. 80 indexed citations

17.

Dong, Jianghong, Shengwei Chen, Runfeng Li, et al.. (2015). Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus. European Journal of Medicinal Chemistry. 108. 605–615. 41 indexed citations

18.

Li, Shang, et al.. (2015). Simvastatin downregulates expression of TGF-βRII and inhibits proliferation of A549 cells via ERK. Tumor Biology. 36(6). 4819–4824. 15 indexed citations

19.

Ye, Hongyu, et al.. (2014). Comparison of the Outcomes of Monopolar and Bipolar Radiofrequency Ablation in Surgical Treatment of Atrial Fibrillation. Chinese Medical Sciences Journal. 29(1). 28–32. 3 indexed citations

20.

Losman, Julie A., Haiming Jiang, Ping‐Ying Pan, et al.. (1999). IL-4 Signaling Is Regulated through the Recruitment of Phosphatases, Kinases, and SOCS Proteins to the Receptor Complex. Cold Spring Harbor Symposia on Quantitative Biology. 64(0). 405–416. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact